Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 8282391, 16 pages
https://doi.org/10.1155/2017/8282391
Review Article

Clinical Outcomes of Specific Immunotherapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

Department of Gastroenterology, Shenyang General Hospital of PLA, No. 83 Wenhua Road Shenyang City, Liaoning 110016, China

Correspondence should be addressed to Guo Xiao-Zhong; moc.nuyila@2691gnohzoaixoug

Received 28 September 2016; Accepted 15 December 2016; Published 7 February 2017

Academic Editor: Sara Trabanelli

Copyright © 2017 Jiang Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Yucai Zhang, Xiaorui Zhang, Ke Li, Kai Qu, and Anqi Zhang, “Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: An up-to-date meta-analysis,” OncoTargets and Therapy, vol. 10, pp. 4173–4192, 2017. View at Publisher · View at Google Scholar
  • Venu G. Pillarisetty, George R. Schade, Matteo Primavera, Joo Ha Hwang, Ezekiel Maloney, Tanya Khokhlova, Elizabeth A. Repasky, Yak-Nam Wang, and Lorenzo Giuliani, “Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy,” International Reviews of Immunology, vol. 36, no. 6, pp. 338–351, 2017. View at Publisher · View at Google Scholar
  • Dakota Rogers, Ava Vila-Leahey, Ana Clara Pessôa, Sharon Oldford, Paola A. Marignani, and Jean S. Marshall, “Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Jian-wei Xu, Lei Wang, Yu-gang Cheng, Guang-yong Zhang, San-yuan Hu, Bin Zhou, and Han-xiang Zhan, “Immunotherapy for pancreatic cancer: A long and hopeful journey,” Cancer Letters, 2018. View at Publisher · View at Google Scholar
  • Fei Li, Johana Gutierrez, Brian Diskin, Mautin Hundeyin, Jill M. Marinis, Pamela Nassau, Julie E. Mosley, Joshua Leinwand, Juan A. Kochen Rossi, Allison M. Beal, Jacqueline I. Kim, Dennis Adeegbe, Ece Bagdatlioglu, Deirdre J. Cohen, John Bertin, George Miller, Yue Wu, Mohammed Khan, Pardeep S. Taunk, Wenyu Su, Wei Wang, Jingjing Wu, Aarif Ahsan, Emma Kurz, Ting Chen, Inedouye Yaboh, Michael Reilly, John D. Lich, Philip A. Harris, Mukesh K. Mahajan, James H. Thorpe, Ankita Mishra, Berk Aykut, Michael Glacken, Atsuo Ochi, Narendra Verma, Varshini Vasudevaraja, Christina Almonte, Kwok-Kin Wong, Shivraj Savadkar, and Nan Wu, “RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer,” Cancer Cell, vol. 34, no. 5, pp. 757–774.e7, 2018. View at Publisher · View at Google Scholar
  • Neus Martinez-Bosch, Judith Vinaixa, and Pilar Navarro, “Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy,” Cancers, vol. 10, no. 1, pp. 6, 2018. View at Publisher · View at Google Scholar
  • Huiqin Liu, Mengnan Sun, Weijian Kong, Jianan Gong, David C.S. Huang, Feng Qian, Zhengsheng Liu, Chao Kong, and Junxiao Ye, “KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs,” Journal of Controlled Release, vol. 296, pp. 40–53, 2019. View at Publisher · View at Google Scholar
  • Xi Zhang, Xi Zhang, Yan Wang, Qin Ouyang, Hara Levy, Hara Levy, and Hara Levy, “The Current Immunoassays and Merging immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases,” Journal of Cancer Genetics and Biomarkers, vol. 1, no. 3, pp. 1–18, 2019. View at Publisher · View at Google Scholar